![](https://cme.uchicago.edu/sites/default/files/styles/course_image/public/course/2023-01/IUCLS.jpg?itok=Ep_7hepX)
20th Annual International Ultmann Chicago Lymphoma Symposium
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies.
![](https://cme.uchicago.edu/sites/default/files/CME-MOC_badge_s.jpg)
Target Audience
Learning Objectives
At the conclusion of this educational activity, participants will be able to:
- Debate the selection and sequencing of the latest advances to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma;
- Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma;
- Evaluate clinical trial data of current and emerging cellular therapy/CAR T-cell approaches for patients with lymphoma, including important safety and efficacy data;
- Review specific patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL;
- Acquire strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.
- 14.50 AMA PRA Category 1 Credit™
- 14.50 Nursing Contact Hours
- 14.50 Participation
Agenda is subject to change.
![](https://cme.uchicago.edu/sites/default/files/styles/hotel_photo/public/course/2023-01/Westin%20River%20North.jpg?itok=EKdWKc3N)
WANT TO KNOW MORE?
SYMPOSIUM CO-CHAIRS
![](https://cme.uchicago.edu/sites/default/files/Sonali%20Smith.jpg)
Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
![](https://cme.uchicago.edu/sites/default/files/Andrew%20Evens.jpg)
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
Medical Director, Oncology Service Line, RWJBarnabas Health
Milwaukee, Wisconsin
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Participants who successfully complete the entire activity and complete an evaluation form will earn 14.5 contact hours.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
REGISTRATION
Preview conference fees below then click the button to register! Early bird rates expire March 21, 2023!
Onsite Registration Available!
Proof of COVID-19 vaccination status is not required to register or attend the conference. However, we strongly recommend staying up to date with CDC vaccine recommendations. To ensure the safety of all attendees, and because of ongoing health risks, particularly to the unvaccinated, participants are expected to adopt the risk mitigation measures (masking and social distancing, etc.) appropriate to their vaccination status as advised by public health officials or to their individual vulnerabilities as advised by a medical professional. Public convening may not be safe for all and carries a risk for contracting COVID-19, particularly for those unvaccinated. Participants will not know the vaccination status of others and should follow appropriate risk mitigation measures.
For questions or concerns, please contact iucls@bioascend.com.
Symposium and InterprofessionalSession
Profession Type | Early Bird Fee | After Early Bird Fee |
---|---|---|
Physician/PharmD/PhD | $325 | $375 |
Nurse/OHP | $150 | $175 |
Fellow/Resident/Student | $125 | $150 |
Industry | $600 | $750 |
Profession Type | Early Bird Fee | After Early Bird Fee |
---|---|---|
Physician/PharmD/PhD | $275 | $325 |
Nurse/OHP | $125 | $150 |
Fellow/Resident/Student | $100 | $125 |
Industry | $450 | $500 |
Profession Type | Early Bird Fee | After Early Bird Fee | |
---|---|---|---|
Physician/PharmD/PhD | $100 | $150 | |
Nurse/OHP | $75 | $100 | |
Fellow/Resident/Student | $75 | $100 | |
Industry | $150 | $200 | |
CANCELLATION POLICY: See website for complete information. |
CLAIMING CREDIT
After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.